| Entry |
|
|---|
| Name |
Pegcetacoplan (USAN/INN);
Empaveli (TN) |
|---|
| Product |
|
|---|
| Formula |
C170H248N50O47S4. (C2H4O)n
|
|---|
| Remark |
|
|---|
| Efficacy |
Complement inhibitor |
|---|
| Disease |
Paroxysmal nocturnal hemoglobinuria [DS: H01053] |
|---|
| Comment |
Treatment of paroxysmal nocturnal hemoglobinuria (PNH), complement-mediated nephropathies, and age-related macular degeneration (AMD)
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
C3 (C3b)
D11613 Pegcetacoplan (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11613
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11613
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
